| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/14/1995 | US5389610 Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors |
| 02/14/1995 | US5389609 Antifungal preparations, and process for making such preparations |
| 02/14/1995 | US5389540 Employing a DNA coding sequence having a (G+C) content that has been increased in the region from nucleotide 410 to the 3' end of the coding sequence relative to wild-type DNA sequence |
| 02/14/1995 | US5389538 Mutant human prourokinase |
| 02/14/1995 | US5389520 Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
| 02/14/1995 | US5389382 Hydrosols of pharmacologically active agents and their pharmaceutical compositions comprising them |
| 02/14/1995 | US5389369 Halo peroxidase containing compositions for killing yeast and sporular microorganisms |
| 02/14/1995 | US5389069 Method and apparatus for in vivo electroporation of remote cells and tissue |
| 02/14/1995 | CA2129763A1 Insulin formulation |
| 02/14/1995 | CA1334390C Glycoprotein growth modulation materials |
| 02/14/1995 | CA1334387C Feline leukemia virus vaccine |
| 02/14/1995 | CA1334386C Method for producing hepatitis b virus proteins in yeast |
| 02/11/1995 | CA2130210A1 Human trh receptor, its production and use |
| 02/10/1995 | EP0661988A4 Composition and treatment with biologically active peptides and chelating agents. |
| 02/10/1995 | CA2129689A1 Identification and use of protease inhibitors |
| 02/09/1995 | WO1995004147A1 Recombinant constructs using replacement sequences in hypervariable regions |
| 02/09/1995 | WO1995004142A2 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 02/09/1995 | WO1995004139A1 Modified dna virus vectors and uses therefor |
| 02/09/1995 | WO1995004135A1 Fungicidal methods and compositions for killing yeast and sporular microorganisms |
| 02/09/1995 | WO1995004081A1 MONOCLONAL IgA ANTIBODY AGAINST RESPIRATORY SYNCYTIAL VIRUS |
| 02/09/1995 | WO1995004080A1 Human antibodies against varicella-zoster virus |
| 02/09/1995 | WO1995004078A1 Cell adhesion protein complexes with copper |
| 02/09/1995 | WO1995004077A1 Method of purifying plasminogen |
| 02/09/1995 | WO1995004075A1 Haemopoietic growth factor antagonists |
| 02/09/1995 | WO1995004069A1 Biotinylation of proteins |
| 02/09/1995 | WO1995004030A1 Therapeutic compound - fatty acid conjugates |
| 02/09/1995 | WO1995003832A1 Intracellular immunization |
| 02/09/1995 | WO1995003828A1 Single-chain immunotoxin compositions and methods for preventing secondary cataracts |
| 02/09/1995 | WO1995003827A1 Method for treating multiple sclerosis |
| 02/09/1995 | WO1995003826A1 Stabilised immunoglobulin preparations and method for preparing same |
| 02/09/1995 | WO1995003823A1 Therapeutic compositions comprising a polypeptide |
| 02/09/1995 | WO1995003822A2 Use of relaxin as therapeutic or preventing agent |
| 02/09/1995 | WO1995003821A1 Prosaposin and cytokine-derived peptides as therapeutic agents |
| 02/09/1995 | WO1995003820A1 Transgenic, cross-linked hemoglobin |
| 02/09/1995 | WO1995003819A1 Regulation of oxidative burst using lmwg-derived peptides and analogs |
| 02/09/1995 | WO1995003818A1 Powder for nasal administration of peptidic or proteinaceous drug |
| 02/09/1995 | WO1995003817A1 Method of treating reproductive disorders |
| 02/09/1995 | WO1995003815A1 Antibodies specific to quinolinic acid |
| 02/09/1995 | WO1995003814A1 Cellular vaccine and methods of use for the treatment of solid tumor malignancies |
| 02/09/1995 | WO1995003804A1 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict |
| 02/09/1995 | WO1995003777A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 02/09/1995 | WO1995003770A1 Methods for b-cell population control |
| 02/09/1995 | WO1995003701A1 Jak kinases and regulation of cytokine signal transduction |
| 02/09/1995 | WO1994022437A3 Method for treating amyloidosis |
| 02/09/1995 | CA2168790A1 Method of treating reproductive disorders |
| 02/09/1995 | CA2168428A1 Antibodies specific to quinolinic acid |
| 02/09/1995 | CA2168349A1 Intracellular immunization |
| 02/09/1995 | CA2168262A1 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict |
| 02/09/1995 | CA2168261A1 Haemopoietic growth factor antagonists |
| 02/09/1995 | CA2168230A1 Human antibodies against varicella-zoster virus |
| 02/09/1995 | CA2168098A1 Jak kinases and regulation of cytokine signal transduction |
| 02/09/1995 | CA2167835A1 Monoclonal iga antibody against respiratory syncytial virus |
| 02/09/1995 | CA2167818A1 Therapeutic compound - fatty acid conjugates |
| 02/09/1995 | CA2167712A1 Process for preparing stabilized immunoglobulins |
| 02/09/1995 | CA2167706A1 Modified dna virus vectors and uses therefor |
| 02/09/1995 | CA2167680A1 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 02/09/1995 | CA2166995A1 Transgenic, cross-linked hemoglobin |
| 02/09/1995 | CA2145515A1 Use of relaxin as therapeutic or preventing agent |
| 02/08/1995 | EP0637593A1 Bispecific trigger molecules recognizing lymphocyte antigen CD2 and tumor antigens |
| 02/08/1995 | EP0637592A1 Processes of producing amylase inhibitors |
| 02/08/1995 | EP0637591A2 A novel expression vector for phytolacca antiviral protein |
| 02/08/1995 | EP0637451A1 Preparation of blood coagulation factor XIII without viruses |
| 02/08/1995 | EP0637450A2 Composition for revitalizing scar tissue |
| 02/08/1995 | EP0637334A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization |
| 02/08/1995 | EP0637333A1 Ifn receptors recognition factors, protein sequences and methods of use thereof |
| 02/08/1995 | EP0637319A1 A novel anti-neoplastic cytokine |
| 02/08/1995 | EP0637318A1 Peptide derivatives corresponding to the carboxy terminal sequence of hirudin |
| 02/08/1995 | EP0637316A1 Antisense oligonucleotide inhibition of papillomavirus |
| 02/08/1995 | EP0637305A1 Novel cyclic amino acids and derivatives thereof |
| 02/08/1995 | EP0637249A1 Suppression of proliferative response and induction of tolerance with polymorphic class ii mhc allopeptides |
| 02/08/1995 | EP0637248A1 Pharmaceutical composition containing cyclosporin derivative |
| 02/08/1995 | EP0637247A1 Treatment of herpesvirus infection |
| 02/08/1995 | EP0637246A1 Methods of treating cancer using modified c-reactive protein |
| 02/08/1995 | EP0637203A1 Regulation of the immune system |
| 02/08/1995 | EP0536203B1 COMBINED TREATMENT WITH GnRH ANTAGONIST AND GnRH TO CONTROL GONADOTROPIN LEVELS IN MAMMALS |
| 02/08/1995 | EP0174981B1 Method of treating depression in vertebrates |
| 02/08/1995 | CN1098409A 2-piperazinone compounds and their use |
| 02/08/1995 | CN1098408A Heterocyclic inhibitors of farnesyl protein transferase |
| 02/07/1995 | US5387746 Pulmonary hydrophobic surfactant-associated protein of 6,000 daltons molecular weight and multimers thereof |
| 02/07/1995 | US5387696 Reductive amination of an amino acid or of an amino acid derivative with an α-keto acid or an α-keto acid derivative |
| 02/07/1995 | US5387673 Active fragments of fibroblast growth factor |
| 02/07/1995 | US5387671 Antiinflammatory agents |
| 02/07/1995 | US5387670 Antibiotic, deoxymulundocandin, a process for its production and its use as medicament |
| 02/07/1995 | US5387610 Treating rheumatoid arthritis, corneal ulceration |
| 02/07/1995 | US5387576 Treatment of hyperproliferative epidermal conditions with activin A |
| 02/07/1995 | US5387520 Treatment of tumor cells in vitro with neurotrophic factors and cell proliferation inhibitors |
| 02/07/1995 | US5387413 Anticoagulation by injecting a solution of a monoclonal antibody produced from hybridomas |
| 02/07/1995 | CA2103693A1 Animal model of the human immune system |
| 02/07/1995 | CA1334287C Biologically active peptides tan-866 |
| 02/05/1995 | CA2103938A1 Method and composition for revitalizing scar tissue |
| 02/04/1995 | CA2104237A1 Agents for diagnosis, treatment and cure of amyotrophic lateral sclerosis in humans |
| 02/03/1995 | CA2129155A1 Virus-inactivated factor xa preparation |
| 02/02/1995 | WO1995003422A1 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 02/02/1995 | WO1995003418A2 Recombinant bcg vaccines |
| 02/02/1995 | WO1995003417A2 Homologously recombinant slow growing mycobacteria and uses therefor |
| 02/02/1995 | WO1995003415A2 Epstein-barr virus dna sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests |
| 02/02/1995 | WO1995003414A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 02/02/1995 | WO1995003411A1 Agonists and antagonists of human interleukin-10 |
| 02/02/1995 | WO1995003410A2 Guanylatcyclase activating peptide i (gcap-i) coding gene |
| 02/02/1995 | WO1995003409A1 Analogues of an anti-thrombin polypeptide and process for their preparation |